Organo-Se BTSAs-enabled performance: From racemic and asymmetric synthesis to click chemistry application
Zhi Zhou(ShanghaiTech University), Wei Yi(State Key Laboratory of Respiratory Disease), Huiying Xu, Yuang Gu(ShanghaiTech University), Liexin Wu(State Key Laboratory of Respiratory Disease), Guang Yang(Shanghai University of Traditional Chinese Medicine), Xi‐Yong Yu(Guangdong General Hospital), Wei Zhang(Guangzhou Experimental Station), Zhaoyong Zhang(Guangzhou Experimental Station), Wei Peng(Changsha University), Lei Ma(Guangzhou Experimental Station), Yan Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jincun Zhao(ShanghaiTech University)
Cited by 37
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
|Cell Reports|2020|450
Rhodium(III)‐Catalyzed Redox‐Neutral Coupling of <i>N</i>‐Phenoxyacetamides and Alkynes with Tunable Selectivity
|Angewandte Chemie International Edition|2013|316
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
|Nature Communications|2020|247